rvix uteri in women Dysplasias (CIN, SIL) of the cervix uteri in womenDysplasias (CIN, SIL) of the cervix uteri in womenPatanov, NIaneva, R
WileyInternational Journal of CancerForslund O, Miriam Elfstrom K, Lamin H, Dillner J. 2018. HPV-mRNA and HPV-DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri. Int J Cancer https://doi.org/10.1002/ijc.31819....
doi:10.1097/00006254-196910000-00023H?eg, KariRoger, ViviObstetrical & Gynecological SurveyHøeg K, Roger V (1968) Dysplasia, carcinoma in situ and invasive carcinoma of the cervix uteri in previously screened women. Scand J Clin Lab Invest 22:173–180...
网络轻度子宫颈异常增生 网络释义 1. 轻度子宫颈异常增生 ICD 10 查询: N ... N87 Dysplasia of cervix uteri 子宫颈异常增生 N870Mild cervical dysplasia轻度子宫颈异常增生... icd-10th.blogspot.com|基于 1 个网页
The Prognostic Value of Eosinophilic Leucocytes in the Stroma of Carcinoma of the Cervix Uteri: A Study of 291 Cases Treated with Radium and Roentgen Therapy LINELL F, MANSSON B. F Linell,B Mansson - 《Acta Radiologica》 被引量: 34发表: 1954年 Natural History of Dysplasia of the Uterine ...
stenosis, and stricture of the cervical channel. Changes in theanatomic structureof thecervix uterilead to the loss of functionality; specifically, a reduction of cervical secretions results in a decrease in the probability of conception, an increase in the spontaneous abortion, an increase in the ...
[Pathologic-anatomic description and basic morphological information for management of dysplasias and carcinomas of the cervix uteri]. Histopathology is the bedrock and cornerstone in the management of malignant tumors. Careful macroscopic description with selection of representative tissue for histologic exam...
Furthermore, in excess of 50% of the uteri with the afore- mentioned neoplastic lesions showed at least one identi- cal p53 gene mutation among lesions of EmGD, serous EIC and/or ESC [98,99]. These findings provide a molec- ular link between EmGD and ESC, one of the basic tenets of...
A method for treating mild dysplasia of cervix uteri (CIN I) caused by papilloma virus comprises the oral use of biologically active additive based on indol-3-carbinol, one capsule twice a day for three months and immunomodulating therapy under periodical cytological control. For controlling the ...
关键词: Cervix Dysplasia Cervix Uteri 宫颈上皮重度增生 子宫颈 DOI: 10.1097/01.AOG.0000152350.10875.02 年份: 2005 收藏 引用 批量引用 报错 分享 全部来源 求助全文 全文购买 万方医学 知网 Wolters Kluwer NCBI ResearchGate 查看更多 相似文献 参考文献...